SCHEMBL7981666

SCHEMBL7981666

CCCCC(=O)Nc1oc(-c2cccc(-c3ccc(OC)cc3)c2O)nc1-c1cccnc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 2/20 0.46
HPGD P15428 6/20 0.45
ALDH1A1 P00352 6/20 0.45
KDM4E B2RXH2 5/20 0.45
HSD17B10 Q99714 4/20 0.45
RAB9A P51151 2/20 0.45
GLA P06280 1/20 0.45
HSP90AA1 P07900 2/20 0.43
SMN1; SMN2 Q16637 5/20 0.43
NPC1 O15118 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C19 P33261 1/20 0.39
ABL1 P00519 2/20 0.39
PDGFRB P09619 1/20 0.39
SRC P12931 1/20 0.39
PDGFRA P16234 1/20 0.39
PRKCA P17252 1/20 0.39
PRKCD Q05655 1/20 0.39
MAPT P10636 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7969453 0.89 HPGD (0.46) KDRHPGDALDH1A1KDM4EHSD17B10
SCHEMBL7981663 0.88 KDR (0.50) KDRHPGDALDH1A1KDM4EHSD17B10
SCHEMBL7744655 0.81 HPGD (0.50) KDRHPGDALDH1A1KDM4EHSD17B10
SCHEMBL7744651 0.80 HPGD (0.51) KDRHPGDALDH1A1KDM4EHSD17B10
SCHEMBL7979621 0.77 KDR (0.50) KDRALDH1A1KDM4ERAB9ASMN1; SMN2
SCHEMBL7744758 0.76 ALDH1A1 (0.46) HPGDALDH1A1KDM4EHSD17B10RAB9A
SCHEMBL7980821 0.76 KDR (0.54) KDRRAB9ANPC1CYP1A2MAPT
SCHEMBL7983601 0.76 KDR (0.53) KDRRAB9ANPC1CYP1A2MAPT
SCHEMBL7739007 0.75 KDR (0.51) KDRHPGDALDH1A1KDM4EHSD17B10
SCHEMBL7739010 0.75 KDR (0.47) KDRHPGDALDH1A1KDM4EHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US claimed